10-Q Filing

Silo Pharma, Inc. CIK: 1514183 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-043390`
Period End Date	20220630
Filing Date	20220801
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	f10q0622_silopharma_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 116 Cash Flow Statement 68 Stockholders Equity 24

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Interest receivable (in Dollars)	`InterestReceivableNoncurrent`	$3.59K	USD	Point-in-time
Interest receivable (in Dollars)	`InterestReceivableNoncurrent`	$3.59K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.84M	USD	Point-in-time
Equity investments	`EquityInvestmentsAtCost`	$420.00K	USD	Point-in-time
Equity investments	`EquityInvestmentsAtCost`	$113.01K	USD	Point-in-time
Prepaid expenses and other current assets - current	`PrepaidExpenseAndOtherAssetsCurrent`	$145.32K	USD	Point-in-time
Prepaid expenses and other current assets - current	`PrepaidExpenseAndOtherAssetsCurrent`	$99.94K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$10.40M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$8.95M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Note receivable - non-current, including interest receivable of $3,590	`OtherAssetsNoncurrent`	$61.21K	USD	Point-in-time
Note receivable - non-current, including interest receivable of $3,590	`OtherAssetsNoncurrent`	$63.59K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses - non-current	`PrepaidExpenseNoncurrent`	$33.74K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Prepaid expenses - non-current	`PrepaidExpenseNoncurrent`	$26.66K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	98.64M	shares	Point-in-time
Total Assets	`Assets`	$9.04M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	99.40M	shares	Point-in-time
Total Assets	`Assets`	$10.49M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	99.40M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	98.64M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableRelatedPartiesCurrent`	$417.94K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableRelatedPartiesCurrent`	$155.92K	USD	Point-in-time
Insurance payable	`LoansPayableCurrent`	$40.82K	USD	Point-in-time
Insurance payable	`LoansPayableCurrent`	-	USD	Point-in-time
Deferred revenue - current portion	`DeferredRevenueCurrent`	$72.10K	USD	Point-in-time
Deferred revenue - current portion	`DeferredRevenueCurrent`	$72.10K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$490.04K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$268.85K	USD	Point-in-time
Deferred revenue - long-term portion	`DeferredRevenueNoncurrent`	$901.83K	USD	Point-in-time
Deferred revenue - long-term portion	`DeferredRevenueNoncurrent`	$937.88K	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$937.88K	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$901.83K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.17M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.43M	USD	Point-in-time
Commitment and Contingencies (see Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitment and Contingencies (see Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 shares authorized; 99,395,304 and 98,636,970 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$9.94K	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 shares authorized; 99,395,304 and 98,636,970 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$9.86K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$12.39M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$12.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.26M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$9.06M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$4.23M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$1.28M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$7.87M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$8.50M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$3.77M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$9.04M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$10.49M	USD	Point-in-time

Income Statement 116 line items

Line Item	Tag	Value	Unit	Period
LICENSE FEE REVENUES:	`LicenseFees`	$36.05K	USD	2 Qtrs
LICENSE FEE REVENUES:	`LicenseFees`	$18.02K	USD	1 Quarter
LICENSE FEE REVENUES:	`LicenseFees`	$35.21K	USD	2 Qtrs
LICENSE FEE REVENUES:	`LicenseFees`	$18.03K	USD	1 Quarter
COST OF REVENUES	`CostOfRevenue`	$2.92K	USD	2 Qtrs
COST OF REVENUES	`CostOfRevenue`	$2.08K	USD	2 Qtrs
COST OF REVENUES	`CostOfRevenue`	$1.46K	USD	1 Quarter
COST OF REVENUES	`CostOfRevenue`	$1.46K	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$16.57K	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$33.13K	USD	2 Qtrs
GROSS PROFIT	`GrossProfit`	$16.57K	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$33.13K	USD	2 Qtrs
Compensation expense	`ShareBasedCompensation`	$54.94K	USD	1 Quarter
Compensation expense	`ShareBasedCompensation`	$227.39K	USD	2 Qtrs
Compensation expense	`ShareBasedCompensation`	$167.23K	USD	2 Qtrs
Compensation expense	`ShareBasedCompensation`	$100.21K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$942.48K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$248.18K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$270.91K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$444.43K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$275.95K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$147.45K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$105.68K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$98.85K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$147.45K	USD	2 Qtrs
Insurance expense	`GeneralInsuranceExpense`	$30.87K	USD	1 Quarter
Insurance expense	`GeneralInsuranceExpense`	$29.02K	USD	1 Quarter
Insurance expense	`GeneralInsuranceExpense`	$50.72K	USD	2 Qtrs
Insurance expense	`GeneralInsuranceExpense`	$64.16K	USD	2 Qtrs
Bad debt recovery	`BadDebtRecoveryExpense`	$-53.50K	USD	2 Qtrs
Bad debt recovery	`BadDebtRecoveryExpense`	$-20.00K	USD	2 Qtrs
Bad debt recovery	`BadDebtRecoveryExpense`	$-46.00K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$45.71K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$62.74K	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$116.73K	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$25.92K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.37M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$510.85K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$453.42K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.05M	USD	2 Qtrs
OPERATING LOSS FROM CONTINUING OPERATIONS	`OperatingIncomeLoss`	$-1.34M	USD	2 Qtrs
OPERATING LOSS FROM CONTINUING OPERATIONS	`OperatingIncomeLoss`	$-494.29K	USD	1 Quarter
OPERATING LOSS FROM CONTINUING OPERATIONS	`OperatingIncomeLoss`	$-436.85K	USD	1 Quarter
OPERATING LOSS FROM CONTINUING OPERATIONS	`OperatingIncomeLoss`	$-1.02M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-1.04K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-2.39K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$792.00	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$377.00	USD	1 Quarter
Other income from equity shares earned for lock up agreement	`OtherIncome`	-	USD	1 Quarter
Other income from equity shares earned for lock up agreement	`OtherIncome`	-	USD	1 Quarter
Other income from equity shares earned for lock up agreement	`OtherIncome`	-	USD	2 Qtrs
Other income from equity shares earned for lock up agreement	`OtherIncome`	$85.73K	USD	2 Qtrs
Gain on forgiveness of PPP note payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain on forgiveness of PPP note payable	`GainsLossesOnExtinguishmentOfDebt`	$19.08K	USD	2 Qtrs
Gain on forgiveness of PPP note payable	`GainsLossesOnExtinguishmentOfDebt`	$19.08K	USD	1 Quarter
Gain on forgiveness of PPP note payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Net realized loss on equity investments	`GainLossOnInvestments`	-	USD	1 Quarter
Net realized loss on equity investments	`GainLossOnInvestments`	-	USD	2 Qtrs
Net realized loss on equity investments	`GainLossOnInvestments`	$-104.70K	USD	2 Qtrs
Net realized loss on equity investments	`GainLossOnInvestments`	$-104.70K	USD	1 Quarter
Net unrealized gain (loss) on equity investments	`UnrealizedGainLossOnEquityInvestments`	$68.75K	USD	2 Qtrs
Net unrealized gain (loss) on equity investments	`UnrealizedGainLossOnEquityInvestments`	$30.00K	USD	1 Quarter
Net unrealized gain (loss) on equity investments	`UnrealizedGainLossOnEquityInvestments`	$-59.51K	USD	1 Quarter
Net unrealized gain (loss) on equity investments	`UnrealizedGainLossOnEquityInvestments`	$-221.31K	USD	2 Qtrs
Other expense	`OtherNonoperatingIncomeExpense`	$-283.00	USD	1 Quarter
Other expense	`OtherNonoperatingIncomeExpense`	$-283.00	USD	2 Qtrs
Other expense	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other expense	`OtherNonoperatingIncomeExpense`	-	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-164.12K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$85.44K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-239.77K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$48.04K	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.26M	USD	2 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.25M	USD	2 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-388.81K	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-658.40K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperations`	$-658.40K	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperations`	$-1.25M	USD	2 Qtrs
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperations`	$-388.81K	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperations`	$-1.26M	USD	2 Qtrs
Loss from discontinued operations, net of tax	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.16K	USD	2 Qtrs
Loss from discontinued operations, net of tax	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	-	USD	1 Quarter
Loss from discontinued operations, net of tax	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-73.18K	USD	1 Quarter
Loss from discontinued operations, net of tax	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-140.15K	USD	2 Qtrs
LOSS FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
LOSS FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-140.15K	USD	2 Qtrs
LOSS FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-73.18K	USD	1 Quarter
LOSS FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.16K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-658.40K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.26M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-461.99K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.39M	USD	2 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$1.40M	USD	2 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	2 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-658.40K	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-461.99K	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-2.80M	USD	2 Qtrs
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-1.26M	USD	2 Qtrs
Continuing operations - basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Continuing operations - basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Continuing operations - basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Continuing operations - basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	2 Qtrs
Discontinued operations - basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Discontinued operations - basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	2 Qtrs
Discontinued operations - basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Discontinued operations - basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	2 Qtrs
Basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.40M	shares	1 Quarter
Basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.02M	shares	2 Qtrs
Basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.86M	shares	1 Quarter
Basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	91.03M	shares	2 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-658.40K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.26M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-461.99K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.39M	USD	2 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-46.00K	USD	2 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-20.00K	USD	2 Qtrs
Stock-based compensation	`EmployeeBenefitsAndShareBasedCompensation`	$74.25K	USD	2 Qtrs
Stock-based compensation	`EmployeeBenefitsAndShareBasedCompensation`	$83.73K	USD	2 Qtrs
Amortization of prepaid stock-based compensation	`AmortizationOfPrepaidStockbasedExpense`	$107.97K	USD	2 Qtrs
Amortization of prepaid stock-based compensation	`AmortizationOfPrepaidStockbasedExpense`	-	USD	2 Qtrs
Net realized gain on equity investments	`IncomeLossFromEquityMethodInvestments`	-	USD	2 Qtrs
Net realized gain on equity investments	`IncomeLossFromEquityMethodInvestments`	$-104.70K	USD	2 Qtrs
Net unrealized loss (gain) loss on equity investments	`UnrealizedGainLossOnInvestments`	$68.75K	USD	2 Qtrs
Net unrealized loss (gain) loss on equity investments	`UnrealizedGainLossOnInvestments`	$-221.31K	USD	2 Qtrs
Equity shares earned for lock up agreement	`EquitySharesEarnedForServices`	$-85.73K	USD	2 Qtrs
Equity shares earned for lock up agreement	`EquitySharesEarnedForServices`	-	USD	2 Qtrs
Gain on forgiveness of PPP note payable and accrued interest	`GainsLossesOnRestructuringOfDebt`	-	USD	2 Qtrs
Gain on forgiveness of PPP note payable and accrued interest	`GainsLossesOnRestructuringOfDebt`	$19.08K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-38.30K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$64.05K	USD	2 Qtrs
Assets of discontinued operations	`IncreaseDecreaseInAssetsOfDiscontinuedOperation`	-	USD	2 Qtrs
Assets of discontinued operations	`IncreaseDecreaseInAssetsOfDiscontinuedOperation`	$-22.12K	USD	2 Qtrs
Interest receivable	`IncreaseDecreaseInReceivables`	-	USD	2 Qtrs
Interest receivable	`IncreaseDecreaseInReceivables`	$2.38K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-262.01K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$65.15K	USD	2 Qtrs
Insurance payable	`IncreaseDecreaseInPayablesToBrokerDealers`	$40.82K	USD	2 Qtrs
Insurance payable	`IncreaseDecreaseInPayablesToBrokerDealers`	-	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$514.79K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-36.05K	USD	2 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-1.19M	USD	2 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-841.06K	USD	2 Qtrs
Net proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	2 Qtrs
Net proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$66.71K	USD	2 Qtrs
Collection on note receivable	`CollectionOnNoteReceivable`	$20.00K	USD	2 Qtrs
Collection on note receivable	`CollectionOnNoteReceivable`	$69.50K	USD	2 Qtrs
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$86.71K	USD	2 Qtrs
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$69.50K	USD	2 Qtrs
Net proceeds from sale of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	2 Qtrs
Net proceeds from sale of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$3.79M	USD	2 Qtrs
Advance from a related party	`AdvanceFromARelatedParty`	$2.37K	USD	2 Qtrs
Advance from a related party	`AdvanceFromARelatedParty`	-	USD	2 Qtrs
Repayment of advance from a related party	`RepaymentsOfRelatedPartyDebt`	$2.37K	USD	2 Qtrs
Repayment of advance from a related party	`RepaymentsOfRelatedPartyDebt`	-	USD	2 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$3.79M	USD	2 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS:	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.10M	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS:	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.02M	USD	2 Qtrs
CASH AND CASH EQUIVALENTS - beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.73M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.84M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.15M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.73M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.84M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.15M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.13M	USD	Point-in-time
Interest	`InterestPaidNet`	$224.00	USD	2 Qtrs
Interest	`InterestPaidNet`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	$25.16K	USD	2 Qtrs
Common stock issued for conversion of Series C preferred stock	`CommonStockIssuedForConversionsOfRedeemableSeriesAPreferredStock`	-	USD	2 Qtrs
Common stock issued for conversion of Series C preferred stock	`CommonStockIssuedForConversionsOfRedeemableSeriesAPreferredStock`	$76.00	USD	2 Qtrs
Iniital fair value of stock options issued as stock-based compensation recorded as deferred compensation	`IniitalFairValueOfStockOptionsIssuedAsStockbasedCompensationRecordedAsDeferredComp`	-	USD	2 Qtrs
Iniital fair value of stock options issued as stock-based compensation recorded as deferred compensation	`IniitalFairValueOfStockOptionsIssuedAsStockbasedCompensationRecordedAsDeferredComp`	$89.55K	USD	2 Qtrs
Common stock warrants granted for services	`StockIssued1`	-	USD	2 Qtrs
Common stock warrants granted for services	`StockIssued1`	$83.73K	USD	2 Qtrs
Increase in equity investments recorded as deferred revenue pursuant to a patent license agreement	`IncreaseInEquityInvestmentsRecordedAsDeferredRevenuePursuantToAPatentLicenseAgree`	$531.25K	USD	2 Qtrs
Increase in equity investments recorded as deferred revenue pursuant to a patent license agreement	`IncreaseInEquityInvestmentsRecordedAsDeferredRevenuePursuantToAPatentLicenseAgree`	-	USD	2 Qtrs

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$9.06M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.87M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.50M	USD	Point-in-time
Balance	`StockholdersEquity`	$3.77M	USD	Point-in-time
Stock options issued as stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$15.11K	USD	1 Quarter
Stock options issued as stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$45.01K	USD	1 Quarter
Amortization of prepaid stock-based compensation	`AmortizationOfPrepaidStockbasedCompensation`	$14.12K	USD	1 Quarter
Common stock issued for conversion of Series C preferred stock	`CommonStockIssuedForConversionOfSeriesCPreferredStock`	-	USD	1 Quarter
Common stock issued for conversion of Series C preferred stock	`CommonStockIssuedForConversionOfSeriesCPreferredStock`	-	USD	1 Quarter
Series C preferred stock issued for cash, net of offering cost	`StockIssuedDuringPeriodValueOther`	$3.79M	USD	1 Quarter
Deemed dividend upon issuance of preferred stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	-	USD	1 Quarter
Common stock warrants granted for services	`StockIssuedDuringPeriodValueIssuedForServices`	$83.73K	USD	1 Quarter
Net loss	`ProfitLoss`	$-930.70K	USD	1 Quarter
Net loss	`ProfitLoss`	$-604.07K	USD	1 Quarter
Net loss	`ProfitLoss`	$-461.99K	USD	1 Quarter
Net loss	`ProfitLoss`	$-658.40K	USD	1 Quarter
Balance	`StockholdersEquity`	$9.06M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.87M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.50M	USD	Point-in-time
Balance	`StockholdersEquity`	$3.77M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.